How Sawyer Hawks of Vanderbilt baseball honors late mother's memory
Sawyer Hawks, a Vanderbilt baseball transfer, is guided by his late mother's memory and by the community that helped raise ...
Modulator shows positive impact on pregnancy outcomes in people with cystic fibrosis
A recent retrospective study published in CHEST evaluated the effects of cystic fibrosis transmembrane conductance regulator ...
Despite Revenue Setback, Arcturus Therapeutics (ARCT) Vaccine Breakthroughs Fuel Optimism
Arcturus Therapeutics (ARCT) had a challenging fourth quarter, with revenue and earnings falling short of analyst ...
Bishop O'Connell High School's Superdance raises over $260k for cystic fibrosis cure
This year, the Superdance went above and beyond its fundraising goal. “We had an original goal of $150,000. But as of ...
Chattanoogan.com22h
Lee University To Host 65 Roses 5K March 29 To Benefit Cystic Fibrosis Research
The 2025 65 Roses 5K will be hosted at Lee University as part of the Great Strides event held to raise funds for a cure for cystic fibrosis. The race will take place on Saturday morning, March 29, ...
PMLive1d
Vertex’s triple combination cystic fibrosis therapy Alyftrek approved by MHRA
Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...
Mirage News5d
Triple Combo Drug Approved for Cystic Fibrosis
In two randomised phase 3 studies involving 480 participants aged 12 years and over, ivacaftor/tezacaftor/vanzacaftor was ...
aftermarketNews2d
Filotimo Foundation Founder Pete Proimos on Cystic Fibrosis Support
Proimos discusses his former aftermarket career at AP Emissions Technologies and the next facet of his life that supports ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment
Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...